Aimfinity & Docter Inc. Merger Approved by Shareholders

Wilmington, DE, March 28, 2025 – Aimfinity Investment Corp. I (Nasdaq: AIMA, AIMAU, AIMAW) announced that its business combination with Docter Inc., a Taiwanese health technology company, was approved at an extraordinary general meeting of shareholders on March 27, 2025. Approximately 93.8% of the votes cast at the EGM were in favor of the Business Combination.

To extend the completion date of the Business Combination from March 28, 2025, to April 28, 2025, I-Fa Chang, manager of AIMA’s sponsor, deposited $55,823.80 into AIMA’s trust account on March 28, 2025, representing $0.05 per Class A ordinary share held by public shareholders.

Pursuant to AIMA’s amended charter, AIMA can extend the completion date monthly until October 28, 2025, by depositing the Monthly Extension Payment. This marks the third of nine monthly extensions available under AIMA's Current Charter.